Nihon Kohden, a global leader in life-support and critical care solutions with over seventy years of clinical expertise, will host two expert-led sessions at the AARC 2025 International Congress in Phoenix, Arizona from December 6 to 9. The sessions will focus on evidence-based strategies for neonatal ventilation and lung recruitability, providing respiratory therapists with actionable guidance for bedside care. In addition, clinical specialists from Nihon Kohden will be available at Booth 905 throughout the event to answer questions and demonstrate the company’s technology.
Health Technology Insights: Datavant and UBC Partner to Advance Patient Access Research
At Booth 905, Nihon Kohden will feature the full NKV Series of ventilators under the theme “Making respiratory care simpler, so caring can come first.” These advanced, data-enabled ventilators streamline workflow and allow clinicians to focus more on patient care. Features such as guided lung recruitment tools, personalized volume-targeting settings, and intuitive app-based interfaces simplify both training and daily use. The NKV Series is designed to support precise, patient-centered care across neonatal, pediatric, and adult populations.
Hong-Lin Du, MD, PhD, President and CEO of Nihon Kohden OrangeMed, LLC, emphasized that every design decision centers on supporting clinicians and improving patient outcomes. Dr. Du stated that at AARC 2025, Nihon Kohden aims to combine live demonstrations of the NKV Series with practical education on real-world topics respiratory therapists face, including reliable volume targeting in the NICU and individualized lung recruitment strategies in critical care.
Health Technology Insights: GE Healthcare to Acquire Intelerad for Cloud Imaging Expansion
The featured Expo Theater sessions include Volume Targeted Ventilation in Extremely Low Birth Weight Neonates, led by Carolyn La Vita, MHA, RRT, RRT-ACCS, RRT-NPS, at 11 a.m. on Sunday, December 7. This session will review the evolution from traditional ventilation modes to evidence-based volume-targeted ventilation for extremely low birth weight infants, highlighting research findings, implementation considerations, and key bedside decision points. The second session, Assessing Lung Recruitability at the Bedside, presented by Marcelo Amato, MD, PhD, at 12 p.m. on December 7, will explore practical techniques for assessing lung recruitability, translating current evidence into safe, individualized approaches to recruitment maneuvers in critically ill patients.
The NKV Series includes ventilators designed to meet specific clinical needs while maintaining core usability, mobility, and reliable performance. The NKV-330 focuses on non-invasive patient comfort, dynamically adapting to mask leaks and synchronizing with patient breathing patterns to improve tolerance and outcomes. The NKV-440 offers turbine-driven mobility in a compact design suitable for critical care, sub-acute, and transport settings, delivering full-featured performance for neonatal, pediatric, and adult patients. The NKV-550 combines advanced technology with versatility for multi-departmental use, integrating the Gentle Lung Suite for guided lung recruitment and assessment, the Protective Control interface for enhanced safety, and an app-based architecture that streamlines training and departmental integration.
Attendees are encouraged to visit Booth 905 to experience hands-on demonstrations and learn how Nihon Kohden’s respiratory care solutions support clinicians in delivering efficient, precise, and patient-focused care across diverse care settings.
Health Technology Insights: Sorcero Raises $42.5 Million to Scale Life Sciences AI
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
